This mini-review aims to summarize the current understanding of the potential use of probiotics (live bacteria or yeasts that confer health benefits when consumed in sufficient quantities), prebiotics (non-digestible substances that promote beneficial bacterial growth), and postbiotics (products made from non-living microorganisms and their components) as treatments for sarcopenia, while also discussing ongoing clinical trials in this area.

Therapeutic perspectives of pre-, pro-, post-biotics in the treatment of sarcopenia

Ticinesi A.
Secondo
;
2024

Abstract

This mini-review aims to summarize the current understanding of the potential use of probiotics (live bacteria or yeasts that confer health benefits when consumed in sufficient quantities), prebiotics (non-digestible substances that promote beneficial bacterial growth), and postbiotics (products made from non-living microorganisms and their components) as treatments for sarcopenia, while also discussing ongoing clinical trials in this area.
2024
Rolland, Y.; Ticinesi, A.; Sokol, H.; Barreto, P. D. S.
File in questo prodotto:
File Dimensione Formato  
Rolland JNHA 2024.pdf

accesso aperto

Descrizione: Full text editoriale
Tipologia: Full text (versione editoriale)
Licenza: Creative commons
Dimensione 228.32 kB
Formato Adobe PDF
228.32 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2591071
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact